Abbreviated 510(k)(Abbreviated 510(k))
A 510(k) pathway that relies on FDA guidance documents, recognized consensus standards, or special controls to establish substantial equivalence.
Usage Examples
- The Abbreviated 510(k) cited FDA recognition of ISO 5832-3 for the orthopedic implant material.
- Conformity to the device-specific special controls per 21 CFR 876.xxxx supported an Abbreviated 510(k).
What is Abbreviated 510(k)?
An Abbreviated 510(k) uses FDA-recognized consensus standards, FDA guidance documents, or device-specific special controls in place of detailed performance testing comparisons with a predicate. The submission format is streamlined: declaration of conformity to the cited standard/guidance replaces extensive testing summaries that would otherwise be required in a Traditional 510(k).
Abbreviated 510(k) is available when an FDA-recognized consensus standard (from FDA's recognized standards database), an FDA guidance document with performance expectations, or device-specific special controls (from Class II classification regulations) applies to the device type. The sponsor declares conformity and provides supporting data demonstrating compliance with the cited basis. Review time is often shorter than Traditional 510(k) because performance conformity is established by reference rather than de novo.
Regulatory Context
This term appears most often in medical devices workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside 21 CFR 807, FDCA SECTION 510K.
When This Matters
- The Abbreviated 510(k) cited FDA recognition of ISO 5832-3 for the orthopedic implant material.
- Conformity to the device-specific special controls per 21 CFR 876.xxxx supported an Abbreviated 510(k).
Common Mistakes
- Using drug-only submission assumptions for device regulatory pathways.
- Ignoring post-market obligations in pre-market planning.
- Weak predicate and classification rationale in dossier narratives.
Related Regulations
Frequently Asked Questions
When an FDA-recognized consensus standard, applicable FDA guidance document, or device-specific special controls cover the performance testing needed for substantial equivalence. If no such reference exists, Traditional 510(k) is required with full testing data.
Often yes. By establishing performance conformity through reference to a recognized standard rather than through de novo testing descriptions, review complexity is reduced. Actual timeline savings depend on the device, but 1-2 months faster than Traditional is common.
Yes, but the format is a declaration of conformity to the cited standard or guidance plus test reports demonstrating compliance. The standard typically defines acceptance criteria; the sponsor's data must show those criteria are met.
Related Terms
Related Use Cases
Prepare 510(k), PMA, and De Novo submissions with AI-guided pathway selection
Manage 15+ client programs from one dashboard with per-client workspaces and tracking
Cut regulatory intelligence tracking from 10+ hours/week to automated, real-time alerts
Track GxP regulation changes and enforcement trends
Related Regulatory Intelligence
Related Actions
Sources & References

